These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27680017)

  • 1. Should low-income countries invest in breast cancer screening?
    Gyawali B; Shimokata T; Honda K; Tsukuura H; Ando Y
    Cancer Causes Control; 2016 Nov; 27(11):1341-1345. PubMed ID: 27680017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
    Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
    BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of breast cancer in countries with limited resources.
    Anderson BO; Braun S; Lim S; Smith RA; Taplin S; Thomas DB;
    Breast J; 2003; 9 Suppl 2():S51-9. PubMed ID: 12713497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity for breast cancer screening in limited resource countries: a literature review and implications for Iran.
    Asadzadeh VF; Broeders MJ; Kiemeney LA; Verbeek AL
    Asian Pac J Cancer Prev; 2011; 12(10):2467-75. PubMed ID: 22320940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward.
    Black E; Richmond R
    Global Health; 2019 Jan; 15(1):3. PubMed ID: 30621753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.
    Al-Foheidi M; Al-Mansour MM; Ibrahim EM
    Med Oncol; 2013 Jun; 30(2):471. PubMed ID: 23420062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review.
    Yoo KB; Kwon JA; Cho E; Kang MH; Nam JM; Choi KS; Kim EK; Choi YJ; Park EC
    Asian Pac J Cancer Prev; 2013; 14(7):4141-9. PubMed ID: 23991967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.
    Yip CH; Smith RA; Anderson BO; Miller AB; Thomas DB; Ang ES; Caffarella RS; Corbex M; Kreps GL; McTiernan A;
    Cancer; 2008 Oct; 113(8 Suppl):2244-56. PubMed ID: 18837017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening in developing countries.
    Panieri E
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):283-90. PubMed ID: 22222136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of mammography intervention in insured very low-income women.
    Ahmed NU; Haber G; Semenya KA; Hargreaves MK
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1790-8. PubMed ID: 20587669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
    Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of an organized breast cancer screening program in Southern Brazil].
    Ribeiro RA; Caleffi M; Polanczyk CA
    Cad Saude Publica; 2013 Nov; 29 Suppl 1():S131-45. PubMed ID: 25402242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.